About
Bio
Contact
Books
News
Papers
Oncology Papers
Evidence Based Medicine
Health Policy
Health Economics
Medical Decision Making
Medical Eduction
Alternative Medicine
Other Papers
Correspondence
Online Only Papers
Other Writing
Speaking
Twitter

Vinay Prasad MD, MPH

About
Bio
Contact
Books
News
Papers
Oncology Papers
Evidence Based Medicine
Health Policy
Health Economics
Medical Decision Making
Medical Eduction
Alternative Medicine
Other Papers
Correspondence
Online Only Papers
Other Writing
Speaking
Twitter
84.jpg

Other Writing

2017

  • Few people actually benefit from ‘breakthrough’ cancer immunotherapy. STAT
  • PSA screening is still a bad deal.  STAT

2016

  • NEJM foolish stance on data sharing

  • The Case for Rationing Cancer Drugs (STAT)

  • Let NPs practice independently (STAT)

  • Why a Cancer Moonshot is Unlikely to Give us a Cure.  (Washington Post)

  • Don't believe what you read about Medical Errors (STAT)

2015

  • Five Years of Cancer Drug Approvals: Most Cost too Much and Give us Too Little. (RAPS invited rebuttal)
  • Why Are Most Cancer Drugs So Expensive. (Guest of Allen Frances at the Huffington Post)
  • Perspective on the Selective reporting of primary, secondary endpoints common in randomized oncology trials. (HemOnc Today)
  • The Folly of Big Science Prizes.  (The New York Times)
  • When Doctors Rely on Promise Instead of Proof.  (Baltimore Sun)
  • Why Lisa Rosenbaum Gets Conflict of Interest Policies Wrong (Lown Institute)

2014

  • Let's Take a Close Look at PARADIGM-HF (CardioExchange)
  • And, the redacted discussion (CardioExchange)

2013

  • President Bush's Cardiac Stent (Washington Post)
  • How Should We Weight Conflicting Advice About our Health (Footnote1.com)

2012

  • Clinical Researchers Meet the Physician Scientists (Kevin MD)
  • Work Hour Reform is a Moral Imperative (Kevin MD)

 

 

 

 

 

 

 

 

 

 


 

 

 

Content Link Block
Select a page and create a visual link to it. Learn more
84.jpg
Other Writing

See more work from Vinay Prasad

Google Scholar →
Back to Top